Project Details
Project Description
Monash Vision Group (MVG) has developed a wireless Brain-Machine Interface (BMI) suitable for treating blindness. With the funding from the BioMedTech Horizons program, MVG proposes to develop in-house capabilities to manufacture the BMI (scheduled for first implantation in humans in early 2019) and commercialise the technology.
| Short title | Commercialisation of GNS |
|---|---|
| Acronym | BMTH |
| Status | Finished |
| Effective start/end date | 23/07/18 → 31/08/20 |
Equipment
-
Centre for Additive Manufacturing (MCAM)
Huang, A. (Manager)
Materials Science & EngineeringFacility/equipment: Facility